BSH 2016: Expert discussion on idelalisib
27 Apr 2016
BSH 2016: Expert discussion on idelalisib
Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance
Next-generation sequencing in the lymphoid malignancies
Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy
Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy
NY-ESO-1 immunotherapy for ovarian cancer
Imaging tumour habitats - life at the edge
Normal and neoplastic stem cells
WIN 2016: Preview of themes
Novel agents before and after stem cell transplantation for myeloma
Immunology highlights from the ITOC-3 conference
EBMT 2016 Highlights: Expert discussion